Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis

British Journal of Psychiatry

Volumn 188, Issue MAY, 2006, Pages 410-415

  Wijkstra, Jaap ^a,e   Lijmer, Jeroen ^b   Balk, Ferdi J ^a   Geddes, John R ^c   Nolen, Willem A ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Waterland Hospital   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMITRIPTYLINE PLUS PERPHENAZINE; AMOXAPINE; BENZATROPINE MESILATE; DESIPRAMINE; DIAZEPAM; FLUOXETINE; FLUOXETINE PLUS OLANZAPINE; FLURAZEPAM; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; LORAZEPAM; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; OXAZEPAM; PAROXETINE; PERPHENAZINE; PLACEBO; SERTRALINE; VALERIAN; VENLAFAXINE;

CLINICAL TRIAL; DEPRESSIVE PSYCHOSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS; REVIEW; SYSTEMATIC REVIEW;

AFFECTIVE DISORDERS, PSYCHOTIC; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 33646501208     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.105.010470     Document Type: Review

References (18)

1. Anton, R. F. & Burch, E. A. (1990) Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. American Journal of Psychiatry, 147, 1203-1208.
2. American Psychiatric Association (2000) Practice Guideline for the Treatment of Patients with Major Depressive Disorder (Revision). Washington, DC: APA.
3. Bellini, L., Gasperini, M., Gatti, F., et al (1994) A double blind study with fluvoxamine vs. desipramine combined with placebo or haloperidol in delusional depression. Critical Issues in the Treatment of Affective Disorders, 9, 32-36.
4. Bruijn, J. A., Moleman, P., Mulder, P. G., et al (1996) A double-bund, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology, 127, 231-237.
5. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmocology, 90, 131-138.
6. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Journal of Affective Disorders, 18, 289-299.
7. Danish University Antidepresasnt Group (1993) Moclobemide: a reversible MAO-A inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Journal of Affective Disorders, 28, 105-116.
8. Mulsant, B. H., Sweet, R. A., Rosen, J., et al (2001) A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. Journal of Clinical Psychiatry, 62, 597-604.
9. National Institute for Clinical Excellence (2004) Depression: Management of Depression in Primary and Secondary Care. Clinical Guideline 23. London: NICE.
10. Nelson, E. B. & McElroy, S. L. (1997) Psychotic depression: a guide to drug choice. CNS drugs, 8, 457-473.
11. Rothschild, A. J., Williamson, D. J., Tohen, M. F., et al (2004) A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. Journal of Clinical Psychopharmacology, 24, 365-373.
12. Spiker, D. G.& Kupfer, D. J. (1988) Placebo response rates in psychotic and nonpsychotic depression. Journal of Affective Disorders, 14, 21-23.
13. Spiker, D. G., Cofsky, W. J., Dealy, R. S., et al (1985) The pharmacological treatment of delusional depression. American Journal of Psychiatry, 42, 430-436.
14. Van den Broek, W. W., Birkenhäger, T. K., Mulder, P. G. H., et al (2004) A double blind study comparing imipramine with fluvoxamine in depressed inpatients. Psychopharmacology, 175, 481-486.
15. Wijkstra, J., Lijmer, J., Balk, F., et al (2005) Pharmacological treatment for psychotic depression. The Cochrane Database of Systematic Reviews, Issue 4. article no. CD004044.pub2. doi: 10.1002/14651858.CD004044.pub2
16. Wheeler Vega, J. A., Mortimer, A. M., & Tyson, P. J. (2000) Somatic treatment of psychotic depression: review and recommendations for practice. Journal of Clinical Psychopharmacology, 20, 504-519.
17. Zanardi, R., Franchini, L., Gasperini, M., et al (1996) Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. American Journal of Psychiatry, 153, 1631-1633.
18. Zanardi, R., Franchini, L., Serrett, A., et al (2000) Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. Journal of Clinical Psychiatry, 61, 26-29.